Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ursodeoxycholic acid adverse reaction |
Causative agent (attribute) |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Allergy to ursodeoxycholic acid |
Causative agent (attribute) |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
|
Ursodeoxycholic acid 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
|
Ursodiol 250mg/5mL sugar free suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
|
Ursodeoxycholic acid 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
|
Ursodeoxycholic acid 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
|
Product containing chenodeoxycholic acid and ursodeoxycholic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Chenodeoxycholic and ursodeoxycholic acid adverse reaction |
Causative agent (attribute) |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Allergy to chenodeoxycholic acid and ursodeoxycholic acid |
Causative agent (attribute) |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
|
Product containing ursodeoxycholic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
|
Ursodeoxycholic acid 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
|
Ursodeoxycholic acid 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
|
Allergy to ursodeoxycholic acid |
Causative agent (attribute) |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
3 |
Allergy to chenodeoxycholic acid and ursodeoxycholic acid |
Causative agent (attribute) |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
3 |
Ursodeoxycholic acid 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 150 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 250 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 300 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 300 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 150 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 250 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid 300 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only chenodeoxycholic acid and ursodeoxycholic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Allergy to ursodeoxycholic acid |
Causative agent (attribute) |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Ursodeoxycholic acid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
1 |
Allergy to chenodeoxycholic acid and ursodeoxycholic acid |
Causative agent (attribute) |
False |
Ursodeoxycholic acid (substance) |
Inferred relationship |
Some |
2 |